Posted in | News | Business | Materials Research

Process Insights Announces Acquisition of Extrel CMS

Process Insights, a portfolio company of Union Park Capital, announced today that it has acquired Extrel CMS, LLC (“Extrel”), the leading manufacturer of research and process mass spectrometers. Extrel, which is based in Pittsburgh, PA, will join Process Insights’ existing portfolio of process instrumentation manufacturers including, COSA Xentaur, Alpha Omega Instruments, Hygrocontrol, LAR Process Analysers, Tiger Optics, and ATOM Instrument as another premium brand within Process Insights. Terms of the transaction were not disclosed.

Extrel has over 50 years of technology innovation and a global customer base across large research and national labs, chemical, refining and pharmaceutical industries. The company was founded in 1964 as Extranuclear Laboratories created by Ted Brackmann and Wade Fite, professors from the University of Pittsburgh, to provide innovative power supplies for mass spectrometry. In 1985 Extranuclear Laboratories became Extrel Corporation to further focus on analytical mass spectrometry products and later in 2004 became Extrel CMS, LLC. Extrel’s products help organizations continuously identify and quantify various molecular components in process environments to ensure safe operations, increase process efficiency and product quality, reduce disruptions and downtime, and attain compliance with numerous and complex regulatory requirements.

“Extrel is a perfect addition to our other Process Insights’ companies. The products and technology are highly complementary to our other businesses and will help us offer a complete solution to our customers,” said Monte Hammouri, CEO of Process Insights. “Extrel’s state-of-the-art mass spectrometers, as well as its after-sales service organization will enhance Process Insights and strengthen our position as a leading provider of process analytical instrumentation. The history and reputation of the Extrel brand as a technical and market leader is second to none. We are thrilled to welcome Extrel to the Process Insights family.”

“I believe that Extrel has great opportunity to take its excellent products and people and reach new markets and customers. Process Insights brings resources and capabilities to support Extrel’s discovery of its potential. As a Process Insights company, Extrel looks forward to working with these businesses to achieve the next chapter of success” added Luke Kephart, President of Extrel.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Process Insights - Mass Spectrometry. (2020, March 16). Process Insights Announces Acquisition of Extrel CMS. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=53092.

  • MLA

    Process Insights - Mass Spectrometry. "Process Insights Announces Acquisition of Extrel CMS". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=53092>.

  • Chicago

    Process Insights - Mass Spectrometry. "Process Insights Announces Acquisition of Extrel CMS". AZoM. https://www.azom.com/news.aspx?newsID=53092. (accessed November 21, 2024).

  • Harvard

    Process Insights - Mass Spectrometry. 2020. Process Insights Announces Acquisition of Extrel CMS. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=53092.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.